Resultados da pesquisa - Daniel Hollyman
- A mostrar 1 - 3 resultados de 3
-
1
K15 Protein of Kaposi’s Sarcoma-Associated Herpesvirus Is Latently Expressed and Binds to HAX-1, a Protein with Antiapoptotic Function Por Tyson V. Sharp, Hsei–Wei Wang, Andrew Koumi, Daniel Hollyman, Yoshio Endo, Hongtao Ye, Ming‐Qing Du, Chris Boshoff
Publicado em 2002Artigo -
2
Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy Por Daniel Hollyman, Jolanta Stefanski, Mark Przybylowski, Shirley Bartido, Oriana Bórquez-Ojeda, Clare Taylor, Raymond Yeh, Vanessa Capacio, Malgorzata Olszewska, James Hosey, Michel Sadelain, Renier J. Brentjens, Isabelle Rivière
Publicado em 2009Artigo -
3
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias Por Renier J. Brentjens, Isabelle Rivière, Jae H. Park, Marco L. Davila, Xiuyan Wang, Jolanta Stefanski, Clare Taylor, Raymond Yeh, Shirley Bartido, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Yvette Bernal, Hollie J. Pegram, Mark Przybylowski, Daniel Hollyman, Yelena Usachenko, Domenick Pirraglia, James Hosey, Elmer Santos, Elizabeth Halton, P. Maslak, David A. Scheinberg, Joseph G. Jurcic, Mark Heaney, Glenn Heller, Mark G. Frattini, Michel Sadelain
Publicado em 2011Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Biology
Adoptive cell transfer
Chronic lymphocytic leukemia
Genetics
Immune system
Immunology
Leukemia
Medicine
T cell
Acute lymphocytic leukemia
Antigen
Biochemistry
CD19
Cancer research
Cell
Cell biology
Cell therapy
Chemotherapy
Chimeric antigen receptor
Cyclophosphamide
Cytotoxic T cell
Ectopic expression
Endoplasmic reticulum
Gastroenterology
Gene
Immunotherapy
In vitro
Internal medicine
Lymphoblastic Leukemia
Minimal residual disease